Linaclotide Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AZN | A | Astrazeneca PLC | 0.53 | |
IRWD | F | Ironwood Pharmaceuticals, Inc. | -1.65 |
Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PPH | B | Market Vectors Pharmaceutical ETF | 5.59 | |
MEDX | F | Horizon Kinetics Medical ETF | 4.77 | |
IBBQ | C | Invesco Nasdaq Biotechnology ETF | 4.7 | |
FLUD | A | Franklin Liberty Ultra Short Bond ETF | 4.07 | |
BIB | D | ProShares Ultra Nasdaq Biotechnology | 3.44 |
Compare ETFs
- Linaclotide
Linaclotide (marketed under the trade name Linzess in the US and Mexico, and as Constella elsewhere) is a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause.
It has a black box warning about the risk of serious dehydration in children in the US; the most common adverse effects in others are gastrointestinal.It is an oligo-peptide agonist of guanylate cyclase 2C and remains in the GI tract after it is taken orally. It was approved in the US and Europe in 2012.It is priced at around $400 for thirty pills in the US and is marketed by Allergan in most of the world and by Astellas in Asia; Ironwood Pharmaceuticals was the originator.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles